Experiment 508838

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationTAMURA,T: SASAKI,Y: EGUCHI,K: SHINKAI,T: OHE,Y: NISHIO,M: KUNIKANE,H: ARIOKA,H: KARATO,A: OMATSU,H: NAKASHIMA,H: SAIJO,N:. (1994). PHASE I AND PHARMACOKINETIC STUDY OF PACLITAXEL BY 24-HOUR INTRAVENOUS INFUSION.. 85(10)
Amount utilized
Compound isolated
DiseaseSTUDIED IN 18 PATIENTS WITH SOLID TUMORS. SIDE EFFECTS INCLUDE GRANULOCYTOPENIAL WITH GRASE 3 INFECTION, LIVER DYSFUNCTION, ALOPECIA, PERIPHERAL NEUROPATHY AND MYALGIA.
Dose amount180.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE